NORGES BANK - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORGES BANK ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$28,483,169
-1.6%
1,024,206
+8.6%
0.01%
-12.5%
Q3 2022$28,953,069
+18.3%
943,404
+13.4%
0.01%
+33.3%
Q2 2022$24,480,139
-10.1%
831,809
-1.7%
0.01%0.0%
Q1 2022$27,217,847
-27.9%
846,063
-0.0%
0.01%
-25.0%
Q4 2021$37,736,000
-12.3%
846,109
-0.8%
0.01%
-20.0%
Q3 2021$43,052,000
-26.0%
853,356
+15.0%
0.01%
-23.1%
Q2 2021$58,201,000
+70.5%
741,980
+24.1%
0.01%
+62.5%
Q1 2021$34,132,000
-52.4%
597,766
-30.2%
0.01%
-52.9%
Q4 2020$71,734,000
+120.9%
856,429
-5.5%
0.02%
+88.9%
Q3 2020$32,475,000
+44.0%
906,373
-2.8%
0.01%
+50.0%
Q2 2020$22,550,000
+35.8%
932,579
-1.7%
0.01%0.0%
Q1 2020$16,609,000
+52.9%
948,538
+52.1%
0.01%
+100.0%
Q4 2019$10,862,000
+13.7%
623,5380.0%0.00%0.0%
Q3 2019$9,553,000
-20.0%
623,538
+8.4%
0.00%
-25.0%
Q2 2019$11,947,000
-10.6%
575,4620.0%0.00%0.0%
Q1 2019$13,362,000
+155.5%
575,462
+116.7%
0.00%
+100.0%
Q1 2018$5,230,000
-48.6%
265,616
-59.1%
0.00%
-50.0%
Q4 2017$10,166,000650,0000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders